Is Pulmonx Corporation overvalued?

Pulmonx Corporation (LUNG) — key valuation metrics and fundamentals.

No verdict

Price

$2.42

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$102.2M

Dividend yield

0.0%

Return on equity

-96.7%

Sector

Healthcare

Fair value compares LUNG's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Aug 2026.

Related stocks